(2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide

C31H45N7O5S — CID 167706622

IUPAC(2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide
SMILESCC(C)C[C@@H]1NC(=O)[C@@H](C)CCCCCC(=O)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)c2nc3ccccc3s2)NC1=O
InChIInChI=1S/C31H45N7O5S/c1-18(2)16-23-28(42)37-24(17-20(39)11-6-4-5-10-19(3)27(41)36-23)29(43)35-22(13-9-15-34-31(32)33)26(40)30-38-21-12-7-8-14-25(21)44-30/h7-8,12,14,18-19,22-24H,4-6,9-11,13,15-17H2,1-3H3,(H,35,43)(H,36,41)(H,37,42)(H4,32,33,34)/t19-,22-,23-,24-/m0/s1
InChIKeyJUXOBRXYOGKHDL-HCUBDLJJSA-N
MW627.81 g/mol
LogP2.59
Rot. Bonds10

About (2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide

(2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide (PubChem CID 167706622) has the molecular formula C31H45N7O5S and a molecular weight of 627.81 g/mol. Its IUPAC name is (2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide.

Molecular Properties

Compound Name(2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide
PubChem CID167706622
Molecular FormulaC31H45N7O5S
Molecular Weight627.81 g/mol
Exact Mass627.32
IUPAC Name(2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide
SMILESCC(C)C[C@@H]1NC(=O)[C@@H](C)CCCCCC(=O)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)c2nc3ccccc3s2)NC1=O
InChIInChI=1S/C31H45N7O5S/c1-18(2)16-23-28(42)37-24(17-20(39)11-6-4-5-10-19(3)27(41)36-23)29(43)35-22(13-9-15-34-31(32)33)26(40)30-38-21-12-7-8-14-25(21)44-30/h7-8,12,14,18-19,22-24H,4-6,9-11,13,15-17H2,1-3H3,(H,35,43)(H,36,41)(H,37,42)(H4,32,33,34)/t19-,22-,23-,24-/m0/s1
InChIKeyJUXOBRXYOGKHDL-HCUBDLJJSA-N
XLogP2.59
TPSA198.73 Ų
H-Bond Donors5
H-Bond Acceptors8
Rotatable Bonds10
Heavy Atoms44
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500627.81
LogP ≤ 52.59
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze (2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide?
The IUPAC name of (2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide (CID 167706622) is (2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide.
What is the SMILES notation for (2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide?
The canonical SMILES for (2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide is CC(C)C[C@@H]1NC(=O)[C@@H](C)CCCCCC(=O)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)c2nc3ccccc3s2)NC1=O.
What is the InChIKey of (2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide?
The InChIKey is JUXOBRXYOGKHDL-HCUBDLJJSA-N. The full InChI is InChI=1S/C31H45N7O5S/c1-18(2)16-23-28(42)37-24(17-20(39)11-6-4-5-10-19(3)27(41)36-23)29(43)35-22(13-9-15-34-31(32)33)26(40)30-38-21-12-7-8-14-25(21)44-30/h7-8,12,14,18-19,22-24H,4-6,9-11,13,15-17H2,1-3H3,(H,35,43)(H,36,41)(H,37,42)(H4,32,33,34)/t19-,22-,23-,24-/m0/s1.
What are the key properties of (2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide?
(2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide has a molecular weight of 627.81 g/mol, XLogP of 2.59, 10 rotatable bonds, 5 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,5S,13S)-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-13-methyl-2-(2-methylpropyl)-3,7,14-trioxo-1,4-diazacyclotetradecane-5-carboxamide is sourced from PubChem (CID 167706622), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).